In the first part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Jim Shehan, chair of the FDA Regulatory practice at Lowenstein Sandler, describes what the approach of pharma companies should be amid the latest/pending tariffs imposed on Canada, Mexico, and China, along with their potential impact on the pharma supply chain.

Business strategies and top news in the biotech / biopharma industry, including market access, supply chain distribution and more.

Business strategies and top news in the biotech / biopharma industry, including market access, supply chain distribution and more.

Aug 11, 2022 · Pharmaceutical distribution today is anything but monolithic. While companies in this space are grappling with issues ranging from inflation and supply chain disruption to workforce scarcity and DSCSA implementation, there’s still plenty of room for smaller players to stake out part of the terrain to call their own

Jan 31, 2025 · In the third part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Donald Prentiss, founder and CEO, Qualthera, explains how collaboration between compounding pharmacies, drug manufacturers, and telehealth platforms can drive success, despite the various litigations pertaining to GLP-1s that are currently taking place.

Feb 2, 2024 · These numbers are also expected to be driven by advances in cancer, neurology, and obesity. The top 10 global Rx sales producers by 2028 will include a few newcomers, indicated by an asterisk in the list ahead.

Dec 5, 2024 · Our December analysis of the twists and turns in the Drug Supply Chain Security Act is a timely one, as the FDA recently again pushed back the deadline for complying with new mandates on tracking and tracing drugs at the package level.

Oct 2, 2024 · Headlining our October issue of Pharmaceutical Commerce is a look inside an emerging key component of cold chain transport and management—ensuring the safety and control of novel injectable drugs through to their "last mile."

Aug 4, 2023 · Creating a user-centric approach that harnesses both digital tools and behavioral science is key to getting—and maintaining—patients on therapy, and improving clinical, financial, and, ultimately, brand-success outcomes for pharma manufacturers.

Click the title above for a link to open the Pharmaceutical Commerce August 2024 issue in an interactive PDF format.